Navigation Links
AmeriCares and AstraZeneca Work Together Delivering Critical Medicines to Help People Living with Chronic Diseases in the U.S.
Date:3/28/2011

STAMFORD, Conn., March 28, 2011 /PRNewswire-USNewswire/ -- AmeriCares and AstraZeneca have teamed to deliver critical medicines to help people living with chronic diseases throughout the United States. AstraZeneca has donated $5 million in cardiovascular and gastrointestinal medications to AmeriCares in support of its Domestic Medical Assistance Program.  The program delivers donated medicines and medical supplies to a network of more than 300 clinics treating the uninsured and underinsured.  Through the AstraZeneca donation, AmeriCares will be able to deliver prescription medications to more than 100 clinics across 38 states.  

"AmeriCares delivery of medical assistance has tripled in just the past two years alone," said Adam Zayan, M.D., vice president of programs at AmeriCares. "With clinics struggling to meet rising demands, this donation from AstraZeneca is crucial to helping people living with chronic diseases. We are so grateful to AstraZeneca for partnering with us so we can increase access to these vital medicines and help restore health to so many people in need throughout the country."

By working together, AmeriCares and AstraZeneca will help clinics across the United States treat patients suffering from chronic health conditions, including acid reflux, hypertension, high cholesterol and cardiovascular diseases, as well as helping to reduce complications stemming from diabetes. Since 2003, AstraZeneca donated essential medicines to AmeriCares valued at more than $63 million.

"Our medicines can only be effective if people have access to them, so these programs are essential," said Jennifer McGovern, director, patient assistance programs, AstraZeneca.

About AmeriCares

AmeriCares is a nonprofit global health and disaster relief organization which delivers medicines, medical supplies and aid to people in need around the world and across the United States.  Since it was established in 1982, AmeriCares has distributed more than $10 billion in humanitarian aid to 147 countries.  For more information, visit www.AmeriCares.org.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

For more information about AstraZeneca in the U.S. or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).

AZ&Me™ is a trademark of the AstraZeneca group of companies.

CONTACT: Donna Porstner

203-658-9579

dporstner@AmeriCares.org


'/>"/>
SOURCE AmeriCares
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AmeriCares Honors Cardinal Health with Power of Partnership Award
2. Medco Partners with AmeriCares to Rush Donated Medicines to Help Victims of the Haiti Earthquake
3. AmeriCares Delivering $1.5 Million in Aid for Libya Crisis
4. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
5. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
6. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
7. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
8. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
9. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
10. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
11. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)...   TrainerMD , the first HIPAA compliant software collaboration platform ... Styku . Styku, a California ... provide users world-class, real-time 3D body scanning and analysis. Together with ... see, hear and feel their health like never before. ... , , ...
(Date:12/5/2016)... 5, 2016  Recently Zymo Research announced an ... known as Horvath,s Clock. Based on this technology, ... service to academic and biopharma scientific researchers to ... other than sperm. The service quantifies ... age versus chronological age following drug treatments and ...
(Date:12/5/2016)... , Dec. 5, 2016 For the ... on the 2017 Human Rights Campaign Foundation,s ... CEI is a national benchmarking tool used to rate ... and transgender (LGBT) employee equality. For the ... to help companies gauge their equality efforts, culture and ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi and ... who do not do their research and undergo cosmetic dermatology treatments from unqualified practitioners ... of a renaissance and every other month a new treatment or device is launched, ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... called the CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial ... healthcare settings. , Over the last 60 years, studies have shown that ...
(Date:12/4/2016)... ... 03, 2016 , ... While James Earl Jones is known for myriad roles ... show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a very ... in large part due to early detection. Like any other disease, treatments have a ...
(Date:12/4/2016)... CA (PRWEB) , ... December 04, 2016 , ... ... without undergoing major cosmetic surgery can now take advantage of a cosmetic procedure ... advanced skin rejuvenation treatment that reduces the appearance of age spots, fine ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in ... Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New ... Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and ...
Breaking Medicine News(10 mins):